These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28803562)

  • 1. Dopamine receptor D2 (DRD2), dopamine transporter solute carrier family C6, member 4 (SLC6A3), and catechol-O-methyltransferase (COMT) genes as moderators of the relation between maternal history of maltreatment and infant emotion regulation.
    Villani V; Ludmer J; Gonzalez A; Levitan R; Kennedy J; Masellis M; Basile VS; Wekerle C; Atkinson L
    Dev Psychopathol; 2018 May; 30(2):581-592. PubMed ID: 28803562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DRD2 and SLC6A3 moderate impact of maternal depressive symptoms on infant cortisol.
    Ludmer JA; Levitan R; Gonzalez A; Kennedy J; Villani V; Masellis M; Basile VS; Atkinson L
    Psychoneuroendocrinology; 2015 Dec; 62():243-51. PubMed ID: 26342565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Dopamine-Related Genes on Neurobehavioral Recovery after Traumatic Brain Injury during Early Childhood.
    Treble-Barna A; Wade SL; Martin LJ; Pilipenko V; Yeates KO; Taylor HG; Kurowski BG
    J Neurotrauma; 2017 Jun; 34(11):1919-1931. PubMed ID: 28323555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal DRD2, SLC6A3, and OXTR genotypes as potential moderators of the relation between maternal history of care and maternal cortisol secretion in the context of mother-infant separation.
    Ludmer JA; Jamieson B; Gonzalez A; Levitan R; Kennedy J; Villani V; Masellis M; Basile VS; Atkinson L
    Biol Psychol; 2017 Oct; 129():154-164. PubMed ID: 28890000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Child maltreatment, impulsivity, and antisocial behavior in African American children: Moderation effects from a cumulative dopaminergic gene index.
    Thibodeau EL; Cicchetti D; Rogosch FA
    Dev Psychopathol; 2015 Nov; 27(4 Pt 2):1621-36. PubMed ID: 26535948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in dopamine system genes are associated with individual differences in attention in infancy.
    Holmboe K; Nemoda Z; Fearon RM; Csibra G; Sasvari-Szekely M; Johnson MH
    Dev Psychol; 2010 Mar; 46(2):404-16. PubMed ID: 20210499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For better and for worse: genes and parenting interact to predict future behavior in romantic relationships.
    Masarik AS; Conger RD; Donnellan MB; Stallings MC; Martin MJ; Schofield TJ; Neppl TK; Scaramella LV; Smolen A; Widaman KF
    J Fam Psychol; 2014 Jun; 28(3):357-67. PubMed ID: 24821524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.
    Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E
    BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commonly-occurring polymorphisms in the COMT, DRD1 and DRD2 genes influence different aspects of motor sequence learning in humans.
    Baetu I; Burns NR; Urry K; Barbante GG; Pitcher JB
    Neurobiol Learn Mem; 2015 Nov; 125():176-88. PubMed ID: 26419600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.
    Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ
    Addict Biol; 2013 Mar; 18(2):344-56. PubMed ID: 22509987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential associations of dopamine-related polymorphisms with discrete components of reaction time variability: relevance for attention deficit/hyperactivity disorder.
    Grant P; Kuepper Y; Wielpuetz C; Hennig J
    Neuropsychobiology; 2014; 69(4):220-6. PubMed ID: 24942140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.
    Kaminskaite M; Jokubka R; Janaviciute J; Lelyte I; Sinkariova L; Pranckeviciene A; Borutaite V; Bunevicius A
    Gene; 2021 Jan; 765():145107. PubMed ID: 32889058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
    Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
    Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-system genes, childhood abuse, and clinical manifestations in women with Bulimia-Spectrum Disorders.
    Groleau P; Steiger H; Joober R; Bruce KR; Israel M; Badawi G; Zeramdini N; Sycz L
    J Psychiatr Res; 2012 Sep; 46(9):1139-45. PubMed ID: 22733030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
    Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
    Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistasis effects of dopamine genes on interval timing and reward magnitude in humans.
    Balcı F; Wiener M; Cavdaroğlu B; Branch Coslett H
    Neuropsychologia; 2013 Jan; 51(2):293-308. PubMed ID: 22903038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations in dopamine and inhibitory control: lack of influence on action restraint.
    Gurvich CT; Rossell SL
    Behav Brain Res; 2014 Jul; 267():12-6. PubMed ID: 24657591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT).
    Benjamin J; Osher Y; Kotler M; Gritsenko I; Nemanov L; Belmaker RH; Ebstein RP
    Mol Psychiatry; 2000 Jan; 5(1):96-100. PubMed ID: 10673775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.